DermTopic: Skin Cancer

Filter Your Results

 

News

 

FDA Approves First Treatment for Rare Form of Skin Cancer

The FDA granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years …

Sunscreen Perceptions, Promotion, and Use: Dermatologists’…

Given that our largest representative body, the American Academy of Dermatology, recommends the use of SPF to minimize U…

Jonathan Wolfe, MD

AAD Throws Some Shade At 26 Schools With 2017 Shade Structur…

The American Academy of Dermatology (AAD) awarded shade structure grants to 26 schools and non-profit organizations acro…

New Biomarker May Help Guide Metastatic Melanoma Treatment D…

Measuring levels of Bim -- a protein made by cancer-fighting T cells -- via a simple blood draw can help doctors predict…

Pierre Fabre and Hill Dermaceuticals Partner in Commercial P…

Pierre Fabre Dermo-Cosmetique and Hill Dermaceuticals, Inc. have entered into a strategic commercial partnership for TOL…

New Research Highlights Need for Greater Sun Safety Educatio…

Taken together, two new studies provide a mixed bag of news on the effectiveness of public health measures and messages …

AAD Launches SkinSerious Campaign

The American Academy of Dermatology is launching a new campaign to raise awareness of the breadth of serious skin diseas…

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.